Diminished inotropic response to amrinone in ventricular myocytes from myopathic hamsters is linked to depression of high-gain Ca2+-induced Ca2+ release

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 2, 2004, Pages 761-773

  Xiong, Wei ^a   Ferrier, Gregory R ^a   Howlett, Susan E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AMRINONE; CAFFEINE; CALCIUM CHANNEL L TYPE; CALCIUM ION; FORSKOLIN; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVATION; HAMSTER; HEART CONTRACTION; HEART VENTRICLE; INOTROPISM; ION CURRENT; MALE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; VOLTAGE CLAMP;

AMRINONE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; CRICETINAE; HEART VENTRICLES; MALE; MUSCULAR DISEASES; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES;

EID: 3343019085     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.064873     Document Type: Article

References (34)

1. 2+-sensitivity of myofibrillar Mg-adenosine triphosphatase isolated from normal human and canine hearts. J Pharmacol Exp Ther 246:30-37.
2. Bers DM (2001) Excitation-Contraction Coupling and Cardiac Contractile Force ed 2, Kluwer Academic Publishers, Boston, MA.
3. Bobet J, Howlett SE, and Gordon T (1991) Possible mechanisms underlying the differences in force production between normal and cardiomyopathy hamster atria. Am J Physiol 261:H1603-H1608.
4. Bohm M, Diet F, Kemkes B, and Erdmann E (1988) Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart. Klin Wochenschr 66:957-962.
5. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, and Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331-339.
6. Ferrier GR and Howlett SE (2003) Differential effects of phosphodiesterase sensitive and resistant analogues of cAMP on initiation of contraction in cardiac ventricular myocytes. J Pharmacol Exp Ther 306:166-178.
7. Ferrier GR, Richard MJP, Shutt RH, and Howlett SE (2004) A separate ultra-high gain CICR mechanism accounts for sigmoidal contraction-voltage relations in cardiac ventricular myocytes when phosphorylation pathways are preserved at physiologic temperature. Biophys J 86:65a.
8. Ferrier GR, Zhu JQ, Redondo IM, and Howlett SE (1998) Role of cAMP-dependent kinase A in activation of a voltage-sensitive release mechanism for cardiac contraction in guinea-pig myocytes. J Physiol (Lond) 513:185-201.
9. Gwathmey JK and Morgan JP (1985) The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret. Br J Pharmacol 85:97-108.
10. Hobai IA, Howarth FC, Pabbathi VK, Dalton GR, Hancox JC, Zhu JQ, Howlett SE, Ferrier GR, and Levi AJ (1997) "Voltage-activated Ca release" in rabbit, rat and guinea-pig cardiac myocytes and modulation by internal cAMP. Pflugers Arch 435:164-173.
11. Howlett SE, Bobet J, and Gordon T (1991) The force-interval relation in normal and cardiomyopathic hamster atria. Am J Physiol 261:H1597-H1602.
12. Howlett SE, Xiong W, Mapplebeck CL, and Ferrier GR (1999) Role of voltage-sensitive release mechanism in depression of cardiac contraction in myopathic hamsters. Am J Physiol 277:H1690-H1700.
13. Hunter EG, Hughes V, and White J (1984) Cardiomyopathic hamsters, CHF 146 and CHF 147: a preliminary study. Can J Physiol Pharmacol 62:1423-1428.
14. Jasmin G and Proschek L (1982) Hereditary polymyopathy and cardiomyopathy in the Syrian hamster: I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle Nerve 5:20-25.
15. Kondo N, Shibata S, Kodama I, and Yamada K (1983) Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle. J Cardiovasc Pharmacol 5:903-912.
16. Li GR, Ferrier GR, and Howlett SE (1995) Calcium currents in ventricular myocytes of prehypertrophic cardiomyopathic hamsters. Am J Physiol 268:H999-H1005.
17. Malecot CO, Arlock P, and Katzung BG (1985) Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets. J Pharmacol Exp Ther 232:10-19.
18. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 88:1197-1201.
19. Morner SE and Wohlfart B (1990) Inotropic mechanisms of amrinone in papillary muscles from guinea-pig hearts. Acta Physiol Scand 139:575-581.
20. Movsesian MA (2002) PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes. Basic Res Cardiol 97:I83-90.
21. Mubagwa K, Shirayama T, Moreau M, and Pappano AJ (1993) Effects of PDE inhibitors and carbachol on the L-type Ca current in guinea pig ventricular myocytes. Am J Physiol 265:H1353-H1363.
22. Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, and Campbell KP (1993) Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem 268:11496-11499.
23. Rosenthal JE and Ferrier GR (1982) Inotropic and electrophysiologic effects of amrinone in untreated and digitalized ventricular tissues, J Pharmacol Exp Ther 221:188-196.
24. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-oka T, and Hanaoka F (1997) Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94:13873-13878.
25. Schmitz W, von der Leyen H, Meyer W, Neumann J, and Scholz H (1989) Phosphodiesterase inhibition and positive inotropic effects. J Cardiovasc Pharmacol 14 (Suppl 3):S11-S14.
26. Shen JB and Pappano AJ (2002) On the role of phosphatase in regulation of cardiac L-type calcium current by cyclic GMP. J Pharmacol Exp Ther 301:501-506.
27. Smith CJ, Huang R, Sun D, Ricketts S, Hoegler C, Ding JZ, Moggio RA, and Hintze TH (1997) Development of decompensated dilated cardiomyopathy is associated with decreased gene expression and activity of the milrinone-sensitive cAMP phosphodiesterase PDE3A. Circulation 96:3116-3123.
28. 2+ current in rat ventricular myocytes. Circ Res 77:803-812.
29. Varro A, Negretti N, Hester SB, and Eisner DA (1993) An estimate of the calcium content of the sarcoplasmic reticulum in rat ventricular myocytes. Pflugers Arch 423:158-160.
30. Wikman-Coffelt J, Sievers R, Parmley WW, and Jasmin G (1986) Verapamil preserves adenine nucleotide pool in cardiomyopathic Syrian hamster. Am J Physiol 250:H22-H28.
31. Xiong W, Moore HM, Howlett SE, and Ferrier GR (2001) In contrast to forskolin and IBMX, amrinone stimulates the cardiac voltage-sensitive release mechanism without increasing calcium-induced calcium release. J Pharmacol Exp Ther 298:954-963.
32. 2+ uptake function of cardiac sarcoplasmic reticulum. Am J Physiol 279:H1898-H1905.
33. Yu H, Cai JJ, and Lee HC (1996) Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts. Mol Pharmacol 50:549-555.
34. 2+-calmodulin-dependent kinase in cardiac myocytes. Am J Physiol 279: H2104-H2115.